Unexo Life Sciences Private Limited: Drug Recall
Recall #D-0065-2025 · 10/24/2024
Class II: Risk
Recall Details
- Recall Number
- D-0065-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Unexo Life Sciences Private Limited
- Status
- Terminated
- Date Initiated
- 10/24/2024
- Location
- New Delhi, India
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 455,536 patches
Reason for Recall
cGMP Deviations
Product Description
THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6 patches (NDC 71101-001-06, UPC 8 45717 01056 6), Manufactured for: Veridian Healthcare, LLC, Gurnee, IL 60031
Distribution Pattern
Nationwide in the US
Other Recalls by Unexo Life Sciences Private Limited
- Class II: Risk 10/24/2024
- Class II: Risk 10/24/2024
- Class II: Risk 10/24/2024
- Class II: Risk 10/24/2024
- Class II: Risk 10/24/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.